BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 23792587)

  • 1. Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junction.
    Clemons NJ; Phillips WA; Lord RV
    Cancer Biol Ther; 2013 Sep; 14(9):782-95. PubMed ID: 23792587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Pathologic Assessment of Gastroesophageal Reflux Disease: The Squamo-Oxyntic Gap.
    Chandrasoma P; DeMeester T
    Adv Exp Med Biol; 2016; 908():41-78. PubMed ID: 27573767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focus on Barrett's esophagus and esophageal adenocarcinoma.
    Paulson TG; Reid BJ
    Cancer Cell; 2004 Jul; 6(1):11-6. PubMed ID: 15261138
    [No Abstract]   [Full Text] [Related]  

  • 4. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma.
    Chang JT; Katzka DA
    Arch Intern Med; 2004 Jul; 164(14):1482-8. PubMed ID: 15277277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Barrett esophagus and inflammation of gastroesophageal junction].
    Voutilainen M; Färkkilä M; Sipponen P
    Duodecim; 2000; 116(17):1899-905. PubMed ID: 12001646
    [No Abstract]   [Full Text] [Related]  

  • 6. [Barrett esophagus: current state of the problem].
    Belova GV; Sokolov VV; Budzinskiĭ AA; Mel'chenko DS
    Eksp Klin Gastroenterol; 2007; (3):36-44. PubMed ID: 17937004
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adenocarcinoma of the gastro-esophagus junction associated to endobrachyesophagus. Two case reports. Review of the literature].
    Kreiker J; Daou R
    J Med Liban; 2004; 52(2):103-10. PubMed ID: 15884690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biology of Barrett's cancer.
    Atherfold PA; Jankowski JA
    Best Pract Res Clin Gastroenterol; 2006; 20(5):813-27. PubMed ID: 16997163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
    Thrift AP
    Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carcinogenesis of Barrett's esophagus].
    Endo T; Sugawara N; Shinomura Y
    Nihon Rinsho; 2005 Aug; 63(8):1357-61. PubMed ID: 16101221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
    Shaheen N; Ransohoff DF
    JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
    Schumpelick V; Dreuw B; Ophoff K; Fass J
    Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophageal adenocarcinoma arising in Barrett esophagus.
    Zhang HY; Spechler SJ; Souza RF
    Cancer Lett; 2009 Mar; 275(2):170-7. PubMed ID: 18703277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction.
    Hamilton SR; Smith RR; Cameron JL
    Hum Pathol; 1988 Aug; 19(8):942-8. PubMed ID: 3402983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
    Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
    Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The columnar lined oesophagus: a riddle wrapped in a mystery inside an enigma.
    Spechler SJ
    Gut; 1997 Nov; 41(5):710-1. PubMed ID: 9414985
    [No Abstract]   [Full Text] [Related]  

  • 17. Carditis, intestinal metaplasia and adenocarcinoma of oesophagogastric junction.
    Conio M; Filiberti R; Blanchi S; Giacosa A
    Eur J Cancer Prev; 2001 Dec; 10(6):483-7. PubMed ID: 11916346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial Barrett esophagus and adenocarcinoma of the gastroesophageal junction.
    Eng C; Spechler SJ; Ruben R; Li FP
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):397-9. PubMed ID: 8348064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus.
    Vallböhmer D; DeMeester SR; Peters JH; Oh DS; Kuramochi H; Shimizu D; Hagen JA; Danenberg KD; Danenberg PV; DeMeester TR; Chandrasoma PT
    Dis Esophagus; 2006; 19(4):260-6. PubMed ID: 16866857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 and p21(WAF1/CIP1/SDI1) gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction.
    Moskaluk CA; Heitmiller R; Zahurak M; Schwab D; Sidransky D; Hamilton SR
    Hum Pathol; 1996 Nov; 27(11):1211-20. PubMed ID: 8912833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.